HomeDXCM • NASDAQ
add
DexCom Inc
Previous close
$138.01
Day range
$125.44 - $138.81
Year range
$74.75 - $142.00
Market cap
49.82B USD
Avg Volume
2.56M
P/E ratio
98.85
Dividend yield
-
Primary exchange
NASDAQ
Top news
Q1 earnings report for Dexcom
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.03B | 26.90% |
Operating expense | 439.70M | 5.72% |
Net income | 256.30M | 179.19% |
Net profit margin | 24.78 | 120.07% |
Earnings per share | 0.50 | 47.06% |
EBITDA | 269.40M | 66.60% |
Effective tax rate | -4.10% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.72B | 10.91% |
Total assets | 6.26B | 16.19% |
Total liabilities | 4.20B | 28.71% |
Total equity | 2.07B | — |
Shares outstanding | 385.52M | — |
Price to book | 25.70 | — |
Return on assets | 8.43% | — |
Return on capital | 11.24% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 256.30M | 179.19% |
Cash from operations | 133.60M | 0.83% |
Cash from investing | 414.90M | 313.76% |
Cash from financing | -631.90M | -63,090.00% |
Net change in cash | -77.30M | -38.53% |
Free cash flow | -56.30M | -171.05% |
About
DexCom, Inc. is a company that develops, manufactures, produces, and distributes continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has manufacturing facilities in Mesa, Arizona and Batu Kawan, Malaysia. Wikipedia
Founded
1999
Headquarters
Website
Employees
9,550